All patients from the age of 4 onward, who present themselves to their practice with one or more new warts of the type vulgaris on hands or feet. MedDRA version: 9.1 Level: LLT Classification code 10010115 Term: Common warts MedDRA version: 9.1 Level: LLT Classification code 10035158 Term: Plantar warts
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients from the age of 4 onward, who present themselves to their practice with one or more new warts of the type vulgaris on hands or feet will be included. New warts are warts which are presented for the first time in general practice by patients who have had no general practice (or dermatological) treatment for warts in the past year. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Immuno-compromised patients Patients with mosaic warts larger than 1 cm in diameter Patients with warts who are pregnant or who are breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary end point(s): ‘Cure', meaning all hand- or plantar wart(s) have totally disappeared (normal skin) at 13 weeks.;Main Objective: Is treatment with monochloroacetic acid more effective than treatment with cryotherapy regarding patients with handwarts? Is treatment with monochloroacetic acid more effective than combination therapy (treatment with first salicylic acid followed by cryotherapy) regarding patients with plantar warts? ;Secondary Objective: To examine the ideas of (parents of) patients having warts, including hindrance of warts, usage of over the counter therapy and expectations concerning over the counter therapy as well as treatment by their general practioner. | — |
Countries
Netherlands